← Read
Sexual Health Screenings: What to Get, How Often, Where
How To
10 min read
Not knowing your status is not the same as being safe. Testing is the only way to actually know.
← Read
The most important thing to understand about sexually transmitted infections is that most of them produce no symptoms - or symptoms so mild and non-specific that they are easily missed or attributed to something else. Chlamydia, the most commonly diagnosed bacterial STI globally, is asymptomatic in approximately 70% of women and 50% of men. HIV produces no symptoms for years in many people while still being transmissible. The absence of symptoms is not a reliable indicator of health status. Testing is.
Most people who have STIs do not know they have them. This is not a statement about behaviour or risk levels - it is a statement about how these infections work biologically. Chlamydia, gonorrhoea, and syphilis in early stages are frequently asymptomatic. HIV can be present for a decade without producing recognisable illness. Herpes is transmitted during periods when no sores are visible. HPV clears in most people without causing noticeable problems, but can persist and cause cervical cell changes that are only detectable by cervical screening.
Untreated STIs have consequences. Untreated chlamydia and gonorrhoea can cause pelvic inflammatory disease (PID) in women, leading to scarring of the fallopian tubes and, in some cases, infertility. Untreated syphilis progresses through stages and can, in its tertiary form, affect the heart and nervous system. Untreated HIV, while no longer a death sentence in the era of antiretroviral therapy, still carries significant health risks and transmissibility. Untreated HPV infection is the primary cause of cervical cancer. These are not catastrophising - they are the documented natural history of infections that are entirely treatable when caught.
Routine testing interrupts these progressions. The argument for testing is not primarily about stigma management or moral accounting - it is simply that knowing your status early produces better health outcomes, for you and for anyone you are sexually active with. The WHO STI guidelines emphasise this explicitly: treatment is more effective earlier, and asymptomatic people who do not test are the primary source of ongoing transmission in most settings.
In the Indian context, stigma around sexual health testing is a significant barrier. The association of STI testing with promiscuity or moral failure is culturally strong and functionally harmful - it delays testing and, when infections are found, often prevents people from seeking treatment promptly. Testing is a routine health behaviour, the same category as blood pressure checks and eye tests, not a confession.
The appropriate testing frequency depends on individual circumstances - specifically, the number of partners, consistency of condom use, and whether any of the risk factors below apply. The following recommendations reflect CDC and WHO guidance, which are internationally recognised clinical standards even where local guidelines vary.
HIV: Annual testing for all sexually active adults with more than one partner. Every 3 months for people at higher risk - those with many partners, inconsistent condom use, or who have a partner with HIV. HIV testing is a blood test, typically paired with pre- and post-test counselling. The window period (time between exposure and accurate test result) with modern fourth-generation tests is approximately 45 days.
Chlamydia and gonorrhoea: Annual testing for all sexually active people under 25. Annual testing for adults of any age with new or multiple partners. Both are tested via urine sample or a swab (vaginal, cervical, anal, or throat, depending on sexual practices). Both are curable with antibiotics when treated; gonorrhoea antibiotic resistance is an increasing concern, making early detection and appropriate treatment more important.
Syphilis: Annual testing for people with multiple partners or higher-risk sexual activity. Syphilis is a blood test. It is fully curable with antibiotics when caught in the primary or secondary stages; later stages require more intensive treatment. India has seen periodic resurgences in syphilis rates, particularly in urban populations.
Hepatitis B and C: A baseline test once for all adults, or at any point of known exposure. Hepatitis B vaccination is available and effective; if unvaccinated, checking immune status and vaccinating is appropriate. Hepatitis C has no vaccine but is now curable with direct-acting antivirals in most cases.
HPV and cervical screening: HPV itself does not have a routine screening test in most Indian healthcare settings; instead, cervical screening (Pap smear or liquid-based cytology) is used to detect the cell changes HPV can cause. Indian guidelines and WHO recommendations align on starting cervical screening from age 25 (some guidelines say 21), with rescreening every 3 years. The HPV vaccine is most effective before first sexual exposure; it is available in India for girls (and increasingly for boys) from age 9 to 26.
India has a national sexual health infrastructure that is substantially underutilised. The most accessible entry points are as follows.
ICTC / ICTC-PP (Integrated Counselling and Testing Centres): These are NACO-run centres attached to government hospitals across India. HIV testing is free and confidential. ICTC staff are trained in non-judgmental counselling. The centres also provide referrals for treatment. A list of ICTC locations is available on the NACO website (naco.gov.in). Waiting times at busy centres can be long; arriving early helps.
Private diagnostic laboratories: SRL Diagnostics, Dr Lal PathLabs, Thyrocare, and Metropolis all offer STI panels that can be booked online with home collection. These panels typically include HIV, hepatitis B, hepatitis C, VDRL (syphilis), and sometimes chlamydia and gonorrhoea. Reports are sent digitally and the process is confidential. The cost for a comprehensive panel ranges from roughly Rs 1,500 to Rs 4,000 depending on what is included.
Private gynaecologists and physicians: For cervical screening (Pap smear) and HPV-related concerns, a private gynaecologist is the most direct route. Many can also order full STI panels. The advantage of this route is continuity of care if results require follow-up.
NGOs and community health organisations: In major cities, organisations working with LGBTQ+ communities and sex workers often provide free or subsidised confidential STI testing with non-judgmental counselling. iHELP (Delhi), Sangama (Bengaluru), and Humsafar Trust (Mumbai) are examples. These organisations are particularly important for people who have reason to be concerned about stigma or discrimination in mainstream healthcare settings.
Online telehealth services: Several telehealth platforms operating in India can arrange home sample collection and provide results with doctor consultation. This is a growing option for people who prefer not to attend a physical clinic. Quality varies; stick to platforms that are registered under the Telemedicine Practice Guidelines 2020.
A sexual health check is straightforward. Depending on which tests you are having and where you are going, it will typically involve a brief consultation (in person, or pre-consultation via telehealth), sample collection, and then waiting for results - usually 24 to 72 hours for most tests.
Sample types vary by test: blood draw for HIV, hepatitis, and syphilis; urine or swab for chlamydia and gonorrhoea; cervical swab for Pap smear. None of these is significantly uncomfortable. If you are going to a government ICTC for HIV testing, there will be a counselling session before the test and a second session when results are given - this is standard procedure and is designed to be supportive.
You do not need to disclose the full details of your sexual history to get tested. You need to give an accurate picture of which types of sexual contact you have had so the right samples are taken. A doctor or nurse who asks about your sexual history is gathering medical information to give you appropriate care, not making a moral judgment. If a healthcare provider responds to your disclosure with judgment or stigma, that is a failure of professional conduct on their part, not a reason to avoid testing in the future.
If you are booking via a private lab, the process is largely administrative: select the panel online, arrange for home collection or attend a collection centre, and wait for your digital report. No consultation is required unless results need follow-up.
A positive result is medical information. It is not a character verdict, a measure of your worth, or a permanent condition in most cases. Here is what is actually true about the most common positive results.
Chlamydia and gonorrhoea are curable with a course of antibiotics. Syphilis in its early stages is cured with a single dose of penicillin or an alternative antibiotic. These are not chronic conditions when treated promptly - treatment clears the infection.
HIV is manageable with antiretroviral therapy (ART). People on effective ART live normal life spans and, when viral load is undetectable, do not transmit the virus to partners (this is the Undetectable = Untransmittable or U=U principle, endorsed by WHO). A positive HIV result in 2026 is very different from what it meant in 1990; it is a chronic manageable condition, not a death sentence. ART is available free through government facilities in India under the NACO programme.
Herpes is a chronic condition with no cure, but it is manageable with antiviral medication that reduces outbreaks and transmission risk. It is also extremely common - estimates suggest a significant proportion of adults carry herpes simplex virus without knowing it.
Hepatitis B and C: Hepatitis B has an effective vaccine; chronic hepatitis B is manageable with antiviral medication. Hepatitis C is now curable in the majority of cases with direct-acting antivirals available in India, including generic versions at affordable cost.
Partner notification is appropriate for bacterial STIs and HIV - letting recent sexual partners know so they can test and treat is the responsible step and, in most cases, the legal norm in India. It does not require sharing your personal details; some health departments offer anonymous partner notification services. If you are unsure how to approach this, a counsellor at an ICTC or NGO can help.